Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander R van Hooff

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cell|April 29, 2014
Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressorsPatrick Kemmeren, Katrin Sameith, Loes A L van de Pasch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinomaSander R van Hooff, Frank K J Leusink, Paul Roepman, et al.
Nature Communications|June 9, 2021
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesisJoshua D G Leach, Nikola Vlahov, Petros Tsantoulis, et al.
NPJ Precision Oncology|January 10, 2026
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncologyMarlinde C Schoonbeek, Pierre Gestraud, Lindy Vernooij, et al.
Cell Reports. Medicine|April 26, 2024
Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastasesSanne Bootsma, Mark P G Dings, Job Kesselaar, et al.
Science Advances|February 6, 2021
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cellGerda Kildisiute, Waleed M Kholosy, Matthew D Young, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Cancer Cell|January 5, 2024
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapyJudith Wienke, Lindy L Visser, Waleed M Kholosy, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2022
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'Karin P S Langenberg, Michael T Meister, Jette J Bakhuizen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2025
Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325]Karin P S Langenberg, Michael T Meister, Jette J Bakhuizen, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell|April 29, 2014
Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressorsPatrick Kemmeren, Katrin Sameith, Loes A L van de Pasch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinomaSander R van Hooff, Frank K J Leusink, Paul Roepman, et al.
Nature Communications|June 9, 2021
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesisJoshua D G Leach, Nikola Vlahov, Petros Tsantoulis, et al.
NPJ Precision Oncology|January 10, 2026
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncologyMarlinde C Schoonbeek, Pierre Gestraud, Lindy Vernooij, et al.
Cell Reports. Medicine|April 26, 2024
Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastasesSanne Bootsma, Mark P G Dings, Job Kesselaar, et al.
Science Advances|February 6, 2021
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cellGerda Kildisiute, Waleed M Kholosy, Matthew D Young, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Cancer Cell|January 5, 2024
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapyJudith Wienke, Lindy L Visser, Waleed M Kholosy, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2022
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'Karin P S Langenberg, Michael T Meister, Jette J Bakhuizen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2025
Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325]Karin P S Langenberg, Michael T Meister, Jette J Bakhuizen, et al.
Pageof 4